Literature DB >> 7492248

Successful application of high dose intravenous immunoglobulins in Sjögren's syndrome associated arthritis.

R A Zeuner, J O Schroeder, F Schröder, H H Euler.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1995        PMID： 7492248      PMCID： PMC1010049          DOI： 10.1136/ard.54.11.936-a

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN： 0003-4967            Impact factor:   19.103


× No keyword cloud information.
  7 in total

1.  Preliminary criteria for the classification of Sjögren's syndrome. Results of a prospective concerted action supported by the European Community.

Authors:  C Vitali; S Bombardieri; H M Moutsopoulos; G Balestrieri; W Bencivelli; R M Bernstein; K B Bjerrum; S Braga; J Coll; S de Vita
Journal:  Arthritis Rheum       Date:  1993-03

2.  Long-term i.v. Ig treatment in systemic lupus erythematosus.

Authors:  C Francioni; M Galeazzi; A Fioravanti; R Gelli; F Megale; R Marcolongo
Journal:  Clin Exp Rheumatol       Date:  1994 Mar-Apr       Impact factor: 4.473

3.  The arthropathy of Sjögren's syndrome.

Authors:  C T Pease; W Shattles; N K Barrett; R N Maini
Journal:  Br J Rheumatol       Date:  1993-07

4.  Effect of high-dose intravenous immunoglobulin therapy on blood rheology.

Authors:  W H Reinhart; P E Berchtold
Journal:  Lancet       Date:  1992-03-14       Impact factor: 79.321

5.  IgG2 deficiency in primary Sjögren's syndrome and hypergammaglobulinemic purpura.

Authors:  P Eriksson; G Almroth; T Denneberg; F D Lindström
Journal:  Clin Immunol Immunopathol       Date:  1994-01

6.  High-dose immunoglobulin therapy as an immunomodulatory treatment of rheumatoid arthritis.

Authors:  B Tumiati; P Casoli; M Veneziani; G Rinaldi
Journal:  Arthritis Rheum       Date:  1992-10

7.  A controlled trial of high-dose intravenous immune globulin infusions as treatment for dermatomyositis.

Authors:  M C Dalakas; I Illa; J M Dambrosia; S A Soueidan; D P Stein; C Otero; S T Dinsmore; S McCrosky
Journal:  N Engl J Med       Date:  1993-12-30       Impact factor: 91.245
  7 in total
  1 in total

Review 1.  Rational drug therapy recommendations for the treatment of patients with Sjögren's syndrome.

Authors:  P Oxholm; J U Prause; M Schiødt
Journal:  Drugs       Date:  1998-09       Impact factor: 9.546
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.